The $43B Big Pharma Story is Starting Over-With a New Player
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
| Open | 24.72 | Prev Close | 24.61 |
| High | 24.99 | Low | 24.54 |
| Volume | 29,072,037 | Volume (Avg) | 55,605 |
| 52 Week High | 27.69 | 52 Week Low | 20.18 |
| Market Cap | 142B | PE Ratio | 14.56 |
General
| Name | Pfizer Inc |
| Ticker | PFE |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 81,000 |
About Pfizer Inc
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Highlights
| Analyst Target | 28.61 |
| Market Cap | 142,021,000,000 |
| PE Ratio | 14.56 |
| PEG Ratio | 3.77 |
| EBITDA | 23,228,000,256 |
Valuation
| Trailing PE | 14.31 |
| Forward PE | 8.67 |
| Price/Sales (Trailing 12 Mt.) | 2.23 |
| Price/Book (Most Recent Quarter) | 1.74 |
Technicals
| Beta | 0.42 |
| 52 Week High | 27.69 |
| 52 Week Low | 20.18 |
| 50 Day Average | 0.94% |
| 200 Day Average | 1.39% |
Dividend
Pfizer Inc pays out a dividend of $1.70 per share, with a dividend yield of 6.79%.
PFE's next dividend payment will be made to shareholders on December 1, 2025.
They pay out 120.11% of their earnings out as a dividend.
Recent Dividends
| Dec 1, 2025 | $0.43 |
| Sep 2, 2025 | $0.43 |
| Jun 13, 2025 | $0.43 |
| Mar 7, 2025 | $0.43 |
| Dec 2, 2024 | $0.42 |
| Sep 3, 2024 | $0.42 |
| Jun 14, 2024 | $0.42 |
| Mar 1, 2024 | $0.42 |
| Dec 4, 2023 | $0.41 |
Marjorie Taylor Greene Buys 6 Stocks: Buffett, Health Care — And This Magnificent 7 Stock
Marjorie Taylor Greene discloses buying more stocks in October. Here's a look at what she added to her portfolio.
Five 2026 vehicles you should absolutely wait for
Don’t buy that new car yet. If you can wait, you’ll have new 2026 model year options that aren’t out yet. Although some models barely change, others are completely redesigned and often get the latest features and improvements. Whether you’re interested in improved fuel economy, cutting-edge technology, or maybe just fresh and distinctive styling, there’s likely a car on the horizon that you’ll be interested in. To ensure you don’t miss out on the latest and greatest, the car experts at Edmunds highlight five vehicles you should consider waiting for.
Trump's New AI Executive Order Will Spark a $10 Trillion Boom - Ad
On July 23, 2025, Trump launched America's AI Action Plan to secure global tech dominance. Morgan Stanley calls it a $10T boom. It's the closest thing to a government-backed wealth transfer-and your chance to get in early.
Hedera Gets Its First ETF: Canary's HBAR Fund Lets Investors Tap Into The Tokenization Boom
Canary Capital Group’s new fund, the Canary HBAR ETF (NASDAQ:HBR), launched on Oct 28, marking a significant expansion of investors’ access to digital assets outside of Bitcoin and Ethereum.
Trump Nominates Jared Isaacman For NASA Administrator — Elon Musk Reacts
Elon Musk's ally Jared Isaacman nominated for NASA Administrator by President Donald Trump amid SpaceX's Artemis push.
Trump's Next Ban - Coming January 19, 2026 (shocking) - Ad
On Jan 19, 2026, Trump is expected to sign an order banning exports of a material every tech firm needs. Not chips-but without it, tech stops. It's his move for U.S. tech dominance. $2T already committed by giants like Apple and NVIDIA. Weeks remain to position before the shift.
Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It
November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.
UPS cargo plane with 3 aboard explodes on takeoff at Louisville airport, igniting huge fire
LOUISVILLE, Ky. (AP) — A large UPS cargo plane with three people aboard crashed Tuesday while taking off from an airport in Louisville, Kentucky, igniting an explosion and massive fire that left a thick plume of black smoke over the area.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
FDA warns websites selling unapproved Botox for cosmetic purposes
Associated Press (AP) — U.S. health regulators on Wednesday sent warning letters to 18 websites selling and similar injectable drugs commonly used to smooth wrinkles.
Denny's to be acquired and taken private in a deal valued at $620 million
Denny's said Monday that it's being acquired by a group on investors in a deal that will take the breakfast chain private.
Why Are 21 Billionaires Moving Their Money ASAP? - Ad
One of the biggest stock market events in 25 years is rapidly unfolding... The economist who predicted the 2008 Financial Crisis says it will be: "The Biggest Crash of Our Lifetime." Starting November 19 it could cut the entire tech marketing by HALF.
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
Why Did MediciNova Stock (MNOV) Jump Over 87% In After-Hours Trading?
MediciNova shares soared over 87% in after-hours trading on Thursday following the publication of promising research.
November 18: D-Day For The Dollar - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on November 18. Investors who make the right moves before then could make up to 40X by 2032...
Shutdown stalemate set to drag into sixth week as Trump pushes Republicans to change Senate rules
WASHINGTON (AP) — Republicans and Democrats remained at a stalemate on the over the weekend as it headed into its sixth week, with for millions of Americans and President Donald Trump pushing GOP leaders to change Senate rules to end it.
Scott Bessent Calls Elon Musk 'One of The Great Entrepreneurs' of This Generation: Says $1 Trillion Pay Package Is For 'Shareholders To Decide'
U.S. Treasury Secretary Scott Bessent praised his former colleague, Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk, while weighing in on his controversial $1 trillion compensation package.
Trump Just Got Authority to BAN This Critical Export - Ad
Trump's next move could reshape tech. He's expected to restrict exports of a key material The New York Times says "powers the world's tech." Action expected Jan 19. $10 trillion at stake. Chipmakers may be forced onshore. A few U.S. firms could see massive gains if you act early.
Why Is Phio Pharmaceuticals Stock Soaring Today?
Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.
Layoffs are piling up, raising worker anxiety. Here are some companies that have cut jobs recently
NEW YORK (AP) — It’s a tough time for the .
On November 18, a powerful new law signed by President Trump will trigger a radical shift in America's money system... - Ad
When a small group of private companies - not the Fed - will perform a major mint of a new kind of money. And those who act before this new system fully kicks in could see gains as high as 40X by 2032. But those who fail to prepare will be blindsided by this sea change to the U.S. dollar.
Trump Reportedly Rebuffs Ukraine Missile Appeal After Putin Call: 'Time To Stop...'
President Donald Trump declined to supply Ukraine with Tomahawk missiles after a tense meeting with Ukrainian President Volodymyr Zelensky at the White House on Friday, according to a report.
Sawyer Merritt Threatens To Move Assets If Charles Schwab Votes Against Elon Musk's Tesla Pay Package: 'I Can't In Good Conscience...'
Sawyer Merritt criticizes Charles Schwab for voting against Musk's $1 trillion pay package, threatening to move assets.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
S&P Global Boosts Outlook As CEO Hails Exceptional Growth
S&P Global (NYSE: SPGI) shares surge after reporting strong Q3 results, beating expectations with adjusted earnings of $4.73 per share.
San Francisco mayor proposes denser housing to tackle affordability crisis
SAN FRANCISCO (AP) — San Francisco Mayor Daniel Lurie is trying to get more homes built for people like Liam Murphy: a fifth-generation city kid who found himself repeatedly outbid for tiny two-bedroom houses that wound up selling for $1.6 million.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Tempus AI Stock (TEM) Slides 6% Overnight: Here's Why The Stock Is Trending
Tempus AI shares fell 6.02% in after-hours trading Tuesday following its third-quarter earnings report.
What to know about the deadly UPS plane crash in Kentucky
LOUISVILLE, Ky. (AP) — At least seven people are dead and 11 others injured after a caught fire and crashed Tuesday while taking off from the company's distribution hub in Louisville, leaving a trail of flames near the runway.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
What to know as the annual sign-up window for health insurance arrives
Higher prices, less help and all hang over health insurance markets as shoppers start looking for coverage this week.
Amazon Strikes $38B OpenAI Deal, Wedbush Hikes Target To Street-High
Wedbush analysts Dan Ives and Scott Devitt raise the price target on Amazon stock from $330 to a Street high of $340
Trump's New AI Executive Order Will Spark a $10 Trillion Boom - Ad
On July 23, 2025, Trump launched America's AI Action Plan to secure global tech dominance. Morgan Stanley calls it a $10T boom. It's the closest thing to a government-backed wealth transfer-and your chance to get in early.
Tesla Sees Demand Drop In Europe In October: Here's How The Company Performed In 9 Key Markets
Tesla vehicle demand could be falling sharply in Europe. Here's a look at the latest figures.
Social Security Faces Insolvency In 7 Years — Committee Proposes COLA Cap For Wealthier Retirees
Proposal to limit Social Security COLAs for high earners aims to prevent insolvency. Checks may increase by 2.8% in 2026.
Trump's Next Ban - Coming January 19, 2026 (shocking) - Ad
On Jan 19, 2026, Trump is expected to sign an order banning exports of a material every tech firm needs. Not chips-but without it, tech stops. It's his move for U.S. tech dominance. $2T already committed by giants like Apple and NVIDIA. Weeks remain to position before the shift.
Zohran Mamdani's Historic Victory Earns Him Congratulations From Bill Ackman, Bernie Sanders — Trump Wasn't 'On The Ballot,' Says President
Democrats win high-profile races despite Trump's absence and shutdown. Zohran Mamdani elected NYC mayor, Abigail Spanberger wins VA governorship, Mikie Sherrill flips NJ.
Elon Musk Calls Out Sam Altman Over Tesla Roadster Refund: 'This Issue Was Fixed and You Received a Refund Within 24 Hours'
Elon Musk and Sam Altman are once again in a public spat, this time over a car.
Elon's New Device Could Launch Biggest IPO of the Decade - Ad
Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.
After winning Trump's $20 billion, President Milei must win votes as Argentine industry reels
BUENOS AIRES, Argentina (AP) — The factory floor used to roar.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.